Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A

20Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

The botulinum neurotoxin serotype A light chain (BoNT/A LC) protease is the catalytic component responsible for the neuroparalysis that is characteristic of the disease state botulism. Three related peptide-like molecules (PLMs) were designed using previous information from co-crystal structures, synthesized, and assayed for in vitro inhibition against BoNT/A LC. Our results indicate these PLMS are competitive inhibitors of the BoNT/A LC protease and their Ki values are in the nM-range. A co-crystal structure for one of these inhibitors was determined and reveals that the PLM, in accord with the goals of our design strategy, simultaneously involves both ionic interactions via its P1 residue and hydrophobic contacts by means of an aromatic group in the P2′ position. The PLM adopts a helical conformation similar to previously determined co-crystal structures of PLMs, although there are also major differences to these other structures such as contacts with specific BoNT/A LC residues. Our structure further demonstrates the remarkable plasticity of the substrate binding cleft of the BoNT/A LC protease and provides a paradigm for iterative structure-based design and development of BoNT/A LC inhibitors. © 2010 Zuniga et al.

Cite

CITATION STYLE

APA

Zuniga, J. E., Hammill, J. T., Drory, O., Nuss, J. E., Burnett, J. C., Gussio, R., … Brunger, A. T. (2010). Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A. PLoS ONE, 5(6). https://doi.org/10.1371/journal.pone.0011378

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free